More Analyses are Needed to Evaluate the Effectiveness of Protection by Vaccines and Previous Infection Against the Omicron Variant of SARS-CoV-2

J Infect Dis. 2022 Sep 13;226(5):942-943. doi: 10.1093/infdis/jiac257.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • COVID-19* / prevention & control
  • Humans
  • SARS-CoV-2 / genetics
  • Viral Vaccines* / immunology

Substances

  • Viral Vaccines

Supplementary concepts

  • SARS-CoV-2 variants